VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Games Workshop Group PLC vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Games Workshop Group PLC
GAW · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Games Workshop Group PLC's moat claims, evidence, and risks.
View GAW analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Games Workshop Group PLC leads (87 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Games Workshop Group PLC has 2 segments (91.5% in Core (Warhammer miniatures & hobby products)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Games Workshop Group PLC has 8 moat types across 4 domains; Sanofi has 5 across 3.
Primary market context
Games Workshop Group PLC
Core (Warhammer miniatures & hobby products)
Tabletop miniature wargaming and related hobby products
Global
Hobbyists/collectors (B2C) plus independent retailers (B2B)
IP owner + designer/manufacturer + distributor + direct-to-consumer retail
91.5%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Games Workshop Group PLC strengths
Sanofi strengths
Segment mix
Games Workshop Group PLC segments
Full profile >Core (Warhammer miniatures & hobby products)
Oligopoly
Licensing (Warhammer IP)
Monopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.